153 related articles for article (PubMed ID: 19302234)
1. Expression profile of Notch-related genes in multidrug resistant K562/A02 cells compared with parental K562 cells.
Yan S; Ma D; Ji M; Guo D; Dai J; Zhao P; Ji C
Int J Lab Hematol; 2010 Apr; 32(2):150-8. PubMed ID: 19302234
[TBL] [Abstract][Full Text] [Related]
2. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
[TBL] [Abstract][Full Text] [Related]
3. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTĪ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
4. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells.
Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM
Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
7. [Effect of YB-1 gene knockdown on human leukemia cell line K562/A02].
Xu WL; Zhou LL; Chen QY; Chen C; Fang LL; Fang XJ; Shen HL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):400-5. PubMed ID: 20017303
[TBL] [Abstract][Full Text] [Related]
8. [Identification of differentially expressed genes involved in multidrug resistance in K562/A02 by cDNA microarray].
Tan YH; Yang CZ; Zhao CH; Qi J; Peng H; Wang JX; Zhou Y; Xiao Y; Lan L
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):328-32. PubMed ID: 15312340
[TBL] [Abstract][Full Text] [Related]
9. Reversal effects of hyaluronan oligosaccharides on adriamycin resistance of K562/A02 cells.
Cui X; Zhou S; Xu H; Zhao T; Liu A; Guo X; Wang F
Anticancer Drugs; 2009 Oct; 20(9):800-6. PubMed ID: 19606017
[TBL] [Abstract][Full Text] [Related]
10. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
Liu L; Zhang M; Zou P; Tian L; Liu F
Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
[TBL] [Abstract][Full Text] [Related]
11. miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.
Li H; Hui L; Xu W
Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):269-77. PubMed ID: 22285729
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
13. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
Liu Y; Xie KM; Yang GQ; Bai XM; Shi YP; Mu HJ; Qiao WZ; Zhang B; Xie P
Cancer Chemother Pharmacol; 2010 Aug; 66(3):433-9. PubMed ID: 19936984
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor c-Jun activation represses mdr-1 gene expression.
Miao ZH; Ding J
Cancer Res; 2003 Aug; 63(15):4527-32. PubMed ID: 12907627
[TBL] [Abstract][Full Text] [Related]
15. [The down regulation of VEGF gene expression may link to change the expression profile of genes in leukemia cell line K562].
Xu WL; Shen HL; Wu ZY; Tang HR; Wang FC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):37-42. PubMed ID: 16456783
[TBL] [Abstract][Full Text] [Related]
16. Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression.
Li H; Hui L; Xu W; Shen H; Chen Q; Long L; Zhu X
Pharm Biol; 2012 Oct; 50(10):1233-40. PubMed ID: 22957792
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562.
Yin DD; Fan FY; Hu XB; Hou LH; Zhang XP; Liu L; Liang YM; Han H
Leuk Res; 2009 Jan; 33(1):109-14. PubMed ID: 18687467
[TBL] [Abstract][Full Text] [Related]
19. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
20. [Identification of multidrug resistance related genes in leukemia by suppression subtractive hybridization].
Zhu NX; Zheng S; Xu RZ; Gao RL; Shen JP; Yu RX
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):14-7. PubMed ID: 12679003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
